Caliway Biopharmaceuticals Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
42
- Stock Symbol
-
6919
- Share Price
-
$2.11
- (As of Thursday Closing)
Caliway Biopharmaceuticals General Information
Description
Caliway Biopharmaceuticals Co Ltd specializes in the development of new drugs for aesthetic medicine and chronic inflammation. The group has one operating segment, which is Healthy Food, and others.
Contact Information
Website
www.caliway.com.twCorporate Office
- 32nd Floor, Unit 9, No.99, Sec. 1
- Xintai 5th Road, Xizhi District
- New Taipei
- Taiwan
Corporate Office
- 32nd Floor, Unit 9, No.99, Sec. 1
- Xintai 5th Road, Xizhi District
- New Taipei
- Taiwan
Caliway Biopharmaceuticals Stock Performance
As of 12-Nov-2026, Caliway Biopharmaceuticals’s stock price is $2.11. Its current market cap is $3.29B with 1.56B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.11 | $2.12 | $1.83 - $5.99 | $3.29B | 1.56B | 7.07M | -$0.01 |
Caliway Biopharmaceuticals Financials Summary
As of 30-Sep-2026, Caliway Biopharmaceuticals has a trailing 12-month revenue of $506K.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,733,015 | 7,488,749 | 2,575,262 | 846,277 |
| Revenue | 506 | 1,219 | 1,385 | 1,250 |
| EBITDA | (28,906) | (17,765) | (19,732) | (15,330) |
| Net Income | (19,357) | (11,281) | (18,349) | (15,682) |
| Total Assets | 287,789 | 302,943 | 297,120 | 124,528 |
| Total Debt | 7,232 | 96 | 361 | 666 |
Caliway Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Caliway Biopharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Caliway Biopharmaceuticals Patents
Caliway Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260124160-A1 | Pharmaceutical formulations of curcumin and/or resveratrol compounds | Pending | 06-Nov-2024 | ||
| WO-2026098542-A1 | Pharmaceutical formulations of curcumin and/or resveratrol compounds | Pending | 06-Nov-2024 | ||
| WO-2026098542-A9 | Pharmaceutical formulations of curcumin and/or resveratrol compounds | Pending | 06-Nov-2024 | ||
| US-20260053755-A1 | Pharmaceutical compositions for use in treating obstructive sleep apnea | Pending | 22-Aug-2024 | ||
| WO-2026041120-A1 | Pharmaceutical compositions for use in treating obstructive sleep apnea | Pending | 22-Aug-2024 | A61K31/121 |
Caliway Biopharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Caliway Biopharmaceuticals ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
33.11 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Caliway Biopharmaceuticals FAQs
-
When was Caliway Biopharmaceuticals founded?
Caliway Biopharmaceuticals was founded in 2012.
-
Where is Caliway Biopharmaceuticals headquartered?
Caliway Biopharmaceuticals is headquartered in New Taipei, Taiwan.
-
What is the size of Caliway Biopharmaceuticals?
Caliway Biopharmaceuticals has 42 total employees.
-
What industry is Caliway Biopharmaceuticals in?
Caliway Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is Caliway Biopharmaceuticals a private or public company?
Caliway Biopharmaceuticals is a Public company.
-
What is Caliway Biopharmaceuticals’s stock symbol?
The ticker symbol for Caliway Biopharmaceuticals is 6919.
-
What is the current stock price of Caliway Biopharmaceuticals?
As of 12-Nov-2026 the stock price of Caliway Biopharmaceuticals is $2.11.
-
What is the current market cap of Caliway Biopharmaceuticals?
The current market capitalization of Caliway Biopharmaceuticals is $3.29B.
-
What is Caliway Biopharmaceuticals’s current revenue?
The trailing twelve month revenue for Caliway Biopharmaceuticals is $506K.
-
What is Caliway Biopharmaceuticals’s annual earnings per share (EPS)?
Caliway Biopharmaceuticals’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
